Get informed when a big investor buys or sells
+ FollowOvervalued by 27.7% based on the discounted cash flow analysis.
Loading insider trades…
Loading congress trades…
| Market cap | $534.43 Million |
|---|---|
| Enterprise Value | $374.42 Million |
| Earnings per Share | $0.5 |
| Beta | 0.63 |
| Outstanding Shares | 102,576,943 |
| P/E Ratio | 11.53 |
|---|---|
| PEG | -11.53 |
| Price to Sales | 0.0 |
| Price to Book Ratio | 2.61 |
| Enterprise Value to Revenue | 0 |
| Enterprise Value to EBIT | 0 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | -0.24 |
| Debt to Equity | 0.09 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
SBC Medical Group Holdings Incorporated provides comprehensive operational support to aesthetic and cosmetic clinics across a global footprint, including Japan, Vietnam, the United States, and other international markets. The company del...
Stockcircle shows 1 open-market insider sale for SBC Medical Group Holdings Incorporated in the last six months from SEC Form 4 reports by executives, directors, and other insiders.
Form 4 insider trades are added as new filings are imported. Top investor 13F holdings refresh after each quarterly filing cycle. Politician trade disclosures are added when new reports are published on Stockcircle.